• Reducing barriers to MRI in patients with CIEDs
    Taken directly from European Heart Journal  Many cardiac pacemakers and defibrillators are not approved by regulators for magnetic resonance imaging (MRI) which makes patient access to MRI challenging, but there is no evidence of increased clinical risk. It is estimated that patients have a 50–75% probability of requiring an MRI during the lifetime of the…
  • Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy
    overall, the results looked great. Hopefully, over the course of the next 12 months, we will finish recruitment for the final phase of the study to further confirm the primary safety and efficacy endpoints that we saw with the….
  • Anticoagulation of Patients with Mechanical Heart Valves.
    The British Cardiovascular Society (BCS) has today released a Joint Statement together with the British Heart Valve Society (BHVS), the Society for Cardiothoracic Surgeons (SCTS), the British Society of Echocardiography (BSE), the Primary Care Cardiovascular Society (PCCS) and the British Congenital Cardiac Association (BCCA) on Anticoagulation of Patients with Mechanical Heart Valves. On 14 July…
  • Prevalence of LA thrombus despite guideline directed anticoagulation – results from a meta-analysis
    Taken directly from the American College of Cardiology A summary by Sarah Kohnstamm, MD, FACC Quick Takes This meta-analysis set out to answer the prevalence of LA thrombus in patients with atrial fibrillation or flutter on guideline-directed anticoagulation. It further identified higher-risk populations in whom the diagnostic yield of a pre-procedure TEE would be beneficial. The…
  • Impact of wearable devices on clinical outcomes and health care utilisation in AF patients
    Summary taken directly from the American College of Cardiology  Quick Takes Patients with AF who use wearable devices for detection of AF are more than twice as likely to undergo an ablation procedure as comparable patients who do not use a wearable device. There is no evidence that use of wearable devices improves heart rate…
  • Techniques to Decrease PPM Implantation Rates Post-TAVR
    Kris Kumar, DO; Firas E. Zahr, MD, FACC; Harsh Golwala, MDExpert Analysis (from the ACC) Quick Takes: Decreasing the degree that the transcatheter heart valve (THV) is within the left ventricular outflow tract (LVOT) can help diminish forces on the conduction apparatus and atrioventricular node, leading to lower rates of conduction abnormalities and permanent pacemaker (PPM) implantation.…
  • Possible inhibition of ICD therapies by newer generation iPhone 12
    The Heart Rhythm Society recently published information regarding an important public health issue concerning the newer generation iPhone 12 which can potentially inhibit lifesaving therapy in a patient, particularly while carrying the phone in upper pockets. The article advises; “Contemporary studies have shown minimal risk of electromagnetic interference with Implantable Cardioverter Defibrillators (ICD’s) and prior…
  • Enhanced Follow Up for Patients with Trifecta Aortic Valve Bioprostheses: A Statement from BHVS, SCTS and BCS
    Statement following a Medical Device Alert issued by the MHRA